JP2007537289A5 - - Google Patents

Download PDF

Info

Publication number
JP2007537289A5
JP2007537289A5 JP2007513391A JP2007513391A JP2007537289A5 JP 2007537289 A5 JP2007537289 A5 JP 2007537289A5 JP 2007513391 A JP2007513391 A JP 2007513391A JP 2007513391 A JP2007513391 A JP 2007513391A JP 2007537289 A5 JP2007537289 A5 JP 2007537289A5
Authority
JP
Japan
Prior art keywords
alkyl
halo
disease
substituted
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007513391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007537289A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/016747 external-priority patent/WO2005113506A1/en
Publication of JP2007537289A publication Critical patent/JP2007537289A/ja
Publication of JP2007537289A5 publication Critical patent/JP2007537289A5/ja
Pending legal-status Critical Current

Links

JP2007513391A 2004-05-14 2005-05-13 Pparモジュレーターとしての化合物および組成物 Pending JP2007537289A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57100404P 2004-05-14 2004-05-14
PCT/US2005/016747 WO2005113506A1 (en) 2004-05-14 2005-05-13 Compounds and compositions as ppar modulators

Publications (2)

Publication Number Publication Date
JP2007537289A JP2007537289A (ja) 2007-12-20
JP2007537289A5 true JP2007537289A5 (cg-RX-API-DMAC7.html) 2008-02-07

Family

ID=35428365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007513391A Pending JP2007537289A (ja) 2004-05-14 2005-05-13 Pparモジュレーターとしての化合物および組成物

Country Status (11)

Country Link
US (1) US7745445B2 (cg-RX-API-DMAC7.html)
EP (1) EP1756062A4 (cg-RX-API-DMAC7.html)
JP (1) JP2007537289A (cg-RX-API-DMAC7.html)
KR (1) KR20070026503A (cg-RX-API-DMAC7.html)
CN (1) CN1980894A (cg-RX-API-DMAC7.html)
AU (1) AU2005245418B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0510024A (cg-RX-API-DMAC7.html)
CA (1) CA2564365A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06013195A (cg-RX-API-DMAC7.html)
RU (1) RU2006144121A (cg-RX-API-DMAC7.html)
WO (1) WO2005113506A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2352085T3 (es) 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.
ES2372617T3 (es) 2005-06-30 2012-01-24 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de ppar-delta.
EP1942921A4 (en) * 2005-10-25 2011-03-09 Merck Sharp & Dohme COMBINATION OF A DIPEPTIDYL-PEPTIDASE-4 HEMMER AND AN ANTIHYPERTENSIVE AGENT FOR THE TREATMENT OF DIABETES AND HYPERTONIA
US20070116756A1 (en) * 2005-11-23 2007-05-24 Dr. Reddy's Laboratories Limited Stable pharmaceutical compositions
MX2008011074A (es) * 2006-03-02 2008-09-10 Warner Chilcott Co Inc Metodo anticonceptivo oral multifasico de ciclo prolongado.
EP1999098A2 (en) * 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
EP2114396A4 (en) * 2006-12-29 2010-03-10 Salk Inst For Biological Studi METHOD FOR IMPROVING TRAINING PERFORMANCE
US8080658B2 (en) * 2007-07-10 2011-12-20 Idemitsu Kosan Co., Ltd. Material for organic electroluminescent element and organic electroluminescent element employing the same
EP2184277B1 (en) * 2007-07-25 2015-07-01 Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China Aryl pyrimidine derivatives, preparation methods and pharmaceutical uses thereof
AU2008338963A1 (en) * 2007-12-13 2009-06-25 Sri International PPAR-delta ligands and methods of their use
WO2009143183A1 (en) * 2008-05-19 2009-11-26 University Of Tennessee Research Foundation, The Pyrimidine non-classical cannabinoid compounds and related methods of use
AU2010242938A1 (en) * 2009-04-30 2011-11-17 Dr. Reddy's Laboratories Ltd. Fixed dose drug combination formulations
KR20120125642A (ko) 2010-02-09 2012-11-16 바이엘 크롭사이언스 아게 히드라진-치환된 안트라닐산 유도체
JP5993846B2 (ja) 2010-06-15 2016-09-14 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH アントラニル酸誘導体
CN103298469A (zh) 2010-08-31 2013-09-11 首尔大学校产学协力财团 PPARδ激动剂的胎儿重编程的用途
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
TWI683808B (zh) * 2017-07-18 2020-02-01 德商菲尼克斯 Fxr有限責任公司 含有胺或(硫)醯胺之lxr調節劑

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665159B1 (fr) * 1990-07-24 1992-11-13 Rhone Poulenc Sante Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
JPH08333287A (ja) * 1995-06-02 1996-12-17 Fuji Yakuhin Kogyo Kk 芳香環置換アルキルカルボン酸及びアルカノール誘導体とそれらを含有する抗血栓剤
KR20020070508A (ko) * 2000-01-28 2002-09-09 노보 노르디스크 에이/에스 프로피온산 유도체 및 당뇨병 및 비만의 치료에 그것의 사용
US6555577B1 (en) * 2000-01-28 2003-04-29 Novo Nordisk A/S Compounds, their preparation and use
AU2002247402A1 (en) * 2001-03-23 2002-10-08 Chugai Seiyaku Kabushiki Kaisha Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
KR20050061562A (ko) * 2002-10-28 2005-06-22 노보 노르디스크 에이/에스 신규 화합물, 그들의 제제 및 사용
ES2352085T3 (es) * 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.

Similar Documents

Publication Publication Date Title
JP7057317B2 (ja) 疾患の治療のための二重機構阻害剤
TWI376370B (en) Compounds for inflammation and immune-related uses
CN101616915B (zh) 调控激酶级联的组合物以及方法
JP2008513516A5 (cg-RX-API-DMAC7.html)
TWI244471B (en) Therapeutic biaryl derivatives
ES2752039T3 (es) Agente terapéutico para la dislipidemia
JP5043105B2 (ja) 有機化合物
CN1379766A (zh) 治疗糖尿病的苯甲酸衍生物
US9737522B2 (en) NMDA receptor modulators and uses related thereto
JP5997156B2 (ja) 癌の治療のための化合物
JP2008513498A5 (cg-RX-API-DMAC7.html)
TW200848026A (en) Dihydroindazole compounds useful in treating iron disorders
TWI691475B (zh) Urat1抑制劑
WO1991001306A1 (en) Oxoindole derivative
RU2006105717A (ru) Производные пиперазина и их применение в качестве терапевтических агентов
JP2016500063A5 (cg-RX-API-DMAC7.html)
TW200843733A (en) Biaryl and biheteroaryl compounds useful in treating iron disorders
EP3210969B1 (en) Kcnq2-5 channel activator
RU2746602C2 (ru) Агонисты ppar, соединения, фармацевтические композиции и способы их применения
WO2013088255A1 (en) Prodrugs of secondary amine compounds
CN101505747A (zh) 作为细胞增殖抑制剂的吡嗪酮
CN105315224A (zh) 环戊基丙烯酰胺衍生物
RU2001120723A (ru) Производные имидазола и их медицинское применение
US11981652B2 (en) GluN2C/D subunit selective antagonists of the N-methyl-D-aspartate receptor
US20250042870A1 (en) Dp antagonist